Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
1.09
Dollar change
-0.01
Percentage change
-0.91
%
Index- P/E- EPS (ttm)-4.42 Insider Own48.42% Shs Outstand5.41M Perf Week14.72%
Market Cap5.90M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.79M Perf Month9.43%
Income-23.94M PEG- EPS next Q- Inst Own7.13% Short Float2.19% Perf Quarter-38.76%
Sales0.16M P/S36.85 EPS this Y- Inst Trans-16.29% Short Ratio1.98 Perf Half Y-36.26%
Book/sh-1.58 P/B- EPS next Y- ROA-51.20% Short Interest0.06M Perf Year-20.44%
Cash/sh0.48 P/C2.28 EPS next 5Y20.00% ROE-1154.18% 52W Range0.83 - 2.62 Perf YTD-39.28%
Dividend Est.- P/FCF- EPS past 5Y0.06% ROI-65.73% 52W High-58.48% Beta4.45
Dividend TTM- Quick Ratio0.37 Sales past 5Y-23.02% Gross Margin-1417.90% 52W Low30.55% ATR (14)0.13
Dividend Ex-Date- Current Ratio0.37 EPS Y/Y TTM18.33% Oper. Margin-13572.84% RSI (14)48.81 Volatility12.35% 11.49%
Employees8 Debt/Eq- Sales Y/Y TTM- Profit Margin-14775.31% Recom1.00 Target Price60.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-20.19% Payout- Rel Volume0.55 Prev Close1.10
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume30.77K Price1.09
SMA205.23% SMA50-15.31% SMA200-37.91% Trades Volume17,046 Change-0.91%
Oct-30-24 08:30AM
Oct-18-24 08:06AM
Oct-17-24 08:00AM
May-14-24 10:53PM
May-10-24 08:00AM
09:31AM Loading…
May-08-24 09:31AM
May-07-24 08:00AM
08:00AM
Mar-15-24 08:53AM
Feb-20-24 08:30AM
Jan-03-24 04:15PM
Dec-21-23 11:18AM
Dec-20-23 04:15PM
Dec-14-23 06:56PM
Nov-02-23 11:48AM
08:30AM Loading…
Nov-01-23 08:30AM
Sep-06-23 01:01PM
09:40AM
08:00AM
Sep-05-23 11:24AM
08:30AM
Jul-18-23 02:24PM
08:00AM
Jul-11-23 11:21AM
08:30AM
May-24-23 11:18AM
08:30AM
May-17-23 08:30AM
May-04-23 08:30AM
May-03-23 01:40PM
07:30AM Loading…
May-02-23 07:30AM
Apr-11-23 08:00AM
Mar-28-23 08:30AM
Mar-20-23 04:10PM
Mar-16-23 07:04AM
Feb-22-23 09:46AM
08:00AM
Jan-04-23 08:30AM
Dec-20-22 08:05AM
Nov-01-22 08:30AM
Oct-18-22 08:30AM
Oct-17-22 08:30AM
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.